Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-07

Clinical Trial Update: DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People Living With HIV-1 Infection [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update comparing DORAvirine-based regimens to Dolutegravir-based regimens in treatment-naïve adults with HIV-1 infection; the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dolutegravir (dolutegravir)
  • Doravirine (doravirine)

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: HIV-1-infection | Phase 3 | Status: RECRUITING